A detailed history of Concourse Financial Group Securities, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1 shares of TNDM stock, worth $33. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$33
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$19.33 - $36.22 $19 - $36
1 New
1 $0
Q2 2023

Aug 10, 2023

BUY
$24.18 - $42.46 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

SELL
$35.86 - $46.5 $14,272 - $18,507
-398 Closed
0 $0
Q4 2022

Jan 30, 2023

BUY
$35.49 - $56.15 $3,513 - $5,558
99 Added 33.11%
398 $0
Q3 2022

Nov 15, 2022

BUY
$43.76 - $68.97 $1,531 - $2,413
35 Added 13.26%
299 $14,000
Q2 2022

Aug 09, 2022

BUY
$53.22 - $123.09 $14,050 - $32,495
264 New
264 $16,000
Q1 2022

May 09, 2022

BUY
$101.89 - $150.09 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$118.18 - $153.21 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$93.51 - $129.4 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$77.0 - $100.19 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$81.28 - $104.34 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$86.4 - $121.75 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

BUY
$95.43 - $116.09 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

SELL
$60.05 - $98.92 $23,779 - $39,172
-396 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$53.13 - $71.19 $21,039 - $28,191
396 New
396 $24,000
Q3 2019

Nov 13, 2019

SELL
$57.11 - $73.3 $26,670 - $34,231
-467 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$54.41 - $71.7 $21,546 - $28,393
396 Added 557.75%
467 $30,000
Q1 2019

May 15, 2019

BUY
$32.25 - $73.56 $2,289 - $5,222
71 New
71 $4,000
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$21.39 - $51.17 $0 - $0
0 New
0 $0

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.14B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.